GENETIC TESTING/

Whole Exome Sequencing

This test shapes what follows.

Exome actually matters

When a diagnosis has been suggested, but not yet defined.

When the next step is unclear, but will shape everything that follows.

When timing matters as much as accuracy.

→ When Should Whole Exome Sequencing Be Considered?

Clinical interpretation defines the outcome

The exome contains most clinically relevant variants,
A single analysis can generate thousands of findings.

Only a few will matter.

The difference is deciding which ones.

HUMAN GENES
0
RESULTS IN DAYS
(REGULAR TAT)
0
RESULTS IN DAYS
(URGENT TAT)
0

Care, Depth, Timing

Each case carries a personal and fragile dimension.

Exome analysis requires depth reasoning at every stage.

Actionable decisions depend on when results become available.

Clinical-grade exome generation

 High-quality sequencing meets clinical responsibility.

Coverage depth

Supports reliable variant interpretation in a clinical context

Variant filtering

Distinguishes noise from clinical signal

Phenotype correlation

Grounds genomic findings in patient reality

Clinical curation

Translates data into actionable insights

Single or trio exome sequencing

Whole exome sequencing can be performed on a single individual or as a trio, including both biological parents.

In some cases, analyzing the patient alone is sufficient.
In others, especially when the clinical picture is complex or requires a more precise interpretation, a trio approach may increase the diagnostic yield.

The choice is clinical, and depends on the individual case.

→ When is a trio approach needed

In some clinical settings, Whole Genome Sequencing (WGS) is increasingly proposed in place of WES or WES trio, based on the idea that broader sequencing is inherently superior.

However, the most effective diagnostic strategy still depends heavily on the clinical context and interpretative structure surrounding the test.

→ WES trio or WGS solo?

Across clinical conditions

From early-onset disorders to adult presentations

Neurodevelopmental


Epilepsies


Congenital Malformations


Metabolic disases


Neuromuscolar disorders


Adult onset diseases

Neurodevelopmental

Epilepsies

Congenital Malformations

Metabolic Disases

Neuromuscolar disorders

Adult onset diseases

Access

Testing follows genetic consultation and can take place in different ways depending on the clinical context and timing:

→ Blood sampling at home with a dedicated nurse
→ In-clinic sampling during consultation (buccal swab)
→ Self-collection using a dedicated buccal swab kit

International patients can be fully managed remotely.

Clinical configurations

EXOME CORE

Whole Exome Sequencing

For cases with a clear clinical question and a targeted analytical scope.

Focused interpretative scope by design. Optimized for standard clinical workflows.
  • 20,000 Human Genes
  • SNV - Single Nucleotide Variations
  • Incidental / Secondary findings
  • Solo / Trio testing
  • mtDNA
  • CNV - Copy Number Variations
  • Secondary Phenotypes
  • Carrier Screening 1st level
  • Urgency: Report in 7 days

EXOME PLUS

Whole Exome Sequencing

For complex cases requiring transversal clinical analysis.

Extended interpretative scope. Includes carrier status and secondary phenotypes.
  • 20,000 Human Genes
  • SNV - Single Nucleotide Variations
  • Incidental / Secondary Findings
  • Solo / Trio Testing
  • mtDNA
  • CNV - Copy Number Variations
  • Secondary Phenotypes
  • Carrier Screening 1st level
  • Urgency: Report in 7 days

EXOME ULTRA-FAST

Whole Exome Sequencing

For cases where diagnostic timing directly impacts clinical care.

Time-critical service for immediate triage and downstream care decisions.
  • Medical Report in 5 days

Sequencing generates data.
Interpretation generates diagnosis.